D Isla
Overview
Explore the profile of D Isla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elez E, Ayala F, Felip E, Garcia Campelo R, Garcia Carbonero R, Garcia Donas J, et al.
ESMO Open
. 2021 Feb;
6(2):100048.
PMID: 33556897
Background: Women represent an increasing proportion of the oncology workforce; however, globally this does not translate into leadership roles, reflecting disparities in career opportunities between men and women. The Spanish...
2.
Isla D, De Castro J, Garcia-Campelo R, Majem M, Vicente D, Juan-Vidal O
Clin Transl Oncol
. 2020 Nov;
23(7):1304-1313.
PMID: 33210237
Aim: To stablish a consensus on the treatment strategy for advanced non-small-cell lung cancer (aNSCLC) with epidermal growth factor receptor mutation (EGFRm) in Spain. Methods: After a systematic literature review,...
3.
Domine M, Moran T, Isla D, Marti J, Sullivan I, Provencio M, et al.
Clin Transl Oncol
. 2020 Feb;
22(2):245-255.
PMID: 32040815
Small-cell lung cancer (SCLC) accounts for 15% of lung cancers. Only one-third of patients are diagnosed at limited stage. The median survival remains to be around 15-20 months without significative...
4.
Garrido P, Conde E, De Castro J, Gomez-Roman J, Felip E, Pijuan L, et al.
Clin Transl Oncol
. 2019 Oct;
22(7):989-1003.
PMID: 31598903
In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) started a joint project to establish guidelines on biomarker testing in patients with advanced...
5.
Isla D, De Castro J, Garcia-Campelo R, Lianes P, Felip E, Garrido P, et al.
Clin Transl Oncol
. 2019 Aug;
22(5):759-771.
PMID: 31368078
Purpose: Immunotherapy-based approaches are standard first-line treatments for advanced/metastatic lung cancer or for chemoradiotherapy consolidation in locally advanced disease. Uncertainty on how to treat patients at disease progression prompted us...
6.
Zugazagoitia J, Ramos I, Trigo J, Palka M, Gomez-Rueda A, Jantus-Lewintre E, et al.
Ann Oncol
. 2018 Dec;
30(2):290-296.
PMID: 30535340
Background: Approximately 30% of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. We have analyzed the clinical utility of next-generation sequencing (NGS) of...
7.
Remon J, Isla D, Garrido P, De Castro J, Majem M, Vinolas N, et al.
Clin Transl Oncol
. 2017 Jun;
19(12):1537-1542.
PMID: 28660482
Background: The WORLD07 project is a female specific database to assess the characteristics of women with lung cancer. Methods: WORLD07 database sets up in 2007, and prospectively stores clinical characteristics,...
8.
Salvador J, Aparicio J, Baron F, Garcia-Campelo R, Garcia-Carbonero R, Lianes P, et al.
Clin Transl Oncol
. 2017 Mar;
19(4):525.
PMID: 28243989
No abstract available.
9.
Gravalos C, Rodriguez C, Sabino A, Segui M, Virizuela J, Carmona A, et al.
Clin Transl Oncol
. 2016 Nov;
18(12):1243-1253.
PMID: 27896639
Bone metastases are common in many advanced solid tumours, being breast, prostate, thyroid, lung, and renal cancer the most prevalent. Bone metastases can produce skeletal-related events (SREs), defined as pathological...
10.
Isla D, Majem M, Vinolas N, Artal A, Blasco A, Felip E, et al.
Clin Transl Oncol
. 2016 Nov;
19(5):527-535.
PMID: 27885542
Lung cancer is the most common cancer globally and has the highest mortality. Although this disease is not associated with a particular gender, its incidence is rising among women, who...